Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs
Open Access
- 15 February 2023
- journal article
- research article
- Published by Springer Nature in npj Vaccines
- Vol. 8 (1) , 1-14
Abstract
There is an urgent need for influenza vaccines providing broader protection that may decrease the need for annual immunization of the human population. We investigated the efficacy of heterologous prime boost immunization with chimpanzee adenovirus (ChAdOx2) and modified vaccinia Ankara (MVA) vectored vaccines, expressing conserved influenza virus nucleoprotein (NP), matrix protein 1 (M1) and neuraminidase (NA) in H1N1pdm09 pre-exposed pigs. We compared the efficacy of intra-nasal, aerosol and intra-muscular vaccine delivery against H3N2 influenza challenge. Aerosol prime boost immunization induced strong local lung T cell and antibody responses and abrogated viral shedding and lung pathology following H3N2 challenge. In contrast, intramuscular immunization induced powerful systemic responses and weak local lung responses but also abolished lung pathology and reduced viral shedding. These results provide valuable insights into the development of a broadly protective influenza vaccine in a highly relevant large animal model and will inform future vaccine and clinical trial design.Keywords
All Related Versions
Funding Information
- RCUK | Medical Research Council (MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1, MR/S037160/1)
- Pirbright Institute (BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039, BBS/E/I/00007031, BBS/E/I/00007037, BBS/E/I/00007039)
This publication has 50 references indexed in Scilit:
- Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1Scientific Reports, 2013
- Kinetics of Lung Lesion Development and Pro-Inflammatory Cytokine Response in Pigs With Vaccine-Associated Enhanced Respiratory Disease Induced by Challenge With Pandemic (2009) A/H1N1 Influenza VirusVeterinary Pathology, 2012
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in HumansClinical Infectious Diseases, 2012
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humansNature Medicine, 2012
- Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesProceedings of the National Academy of Sciences, 2011
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young ChildrenThe Journal of Infectious Diseases, 2011
- Toward a broadly protective influenza vaccineJournal of Clinical Investigation, 2008
- Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineVaccine, 2005
- Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in CanadaJournal of Medical Virology, 2002
- Cytotoxic T-Cell Immunity to InfluenzaNew England Journal of Medicine, 1983